XenoTherapeutics
2016
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Grant
LATEST DEAL TYPE
3
INVESTORS
Description
Developer of human tissue substitute intended for the treatment of severe burns and chronic wounds. The company's human tissue substitute is derived from special, genetically modified pigs by using xenoskin graft technology, enabling burn victims to access an affordable, safe and plentiful treatment whenever is necessary.
Website
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
- PO BOX 130112
- Boston, MA 02113
- United States
+1 (617) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore XenoTherapeutics’s full profile, request a free trial.
XenoTherapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | Completed | Startup | ||||
| 2. Grant | 27-Jan-2017 | 0000 | Completed | Startup | ||
| 1. Grant | 19-May-2016 | Completed | Startup |
XenoTherapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| John Flatley Company | Corporation | 000 0000 | 000000 0 | |||
| MassChallenge | Accelerator/Incubator | 000 0000 | 000000 0 | |||
| Columbia Technology Ventures | University | Minority | 000 0000 | 000000 0 |
XenoTherapeutics Executive Team (5)
XenoTherapeutics Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Michael Yaremchuk | XenoTherapeutics | Trustee of Board | 000 0000 | |
| Paul Barrett | XenoTherapeutics | Chairman | 000 0000 |
1 Former Board Member
You’re viewing 2 of 3 board members. Get the full list »